Transchem Limited
Transchem Limited Fundamental Analysis
Transchem Limited (TRANSCHEM.BO) shows weak financial fundamentals with a PE ratio of 74.54, profit margin of 1.21%, and ROE of 3.70%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 60.9/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze TRANSCHEM.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakTRANSCHEM.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateTRANSCHEM.BO shows balanced valuation metrics.
Growth Score
ModerateTRANSCHEM.BO shows steady but slowing expansion.
Financial Health Score
ExcellentTRANSCHEM.BO maintains a strong and stable balance sheet.
Profitability Score
WeakTRANSCHEM.BO struggles to sustain strong margins.
Key Financial Metrics
Is TRANSCHEM.BO Expensive or Cheap?
P/E Ratio
TRANSCHEM.BO trades at 74.54 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, TRANSCHEM.BO's PEG of -3.29 indicates potential undervaluation.
Price to Book
The market values Transchem Limited at 2.70 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -191.43 times EBITDA. This is generally considered low.
How Well Does TRANSCHEM.BO Make Money?
Net Profit Margin
For every $100 in sales, Transchem Limited keeps $1.21 as profit after all expenses.
Operating Margin
Core operations generate -1.05 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $3.70 in profit for every $100 of shareholder equity.
ROA
Transchem Limited generates $3.59 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Transchem Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Transchem Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
TRANSCHEM.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
74.54
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-3.29
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.70
vs 25 benchmark
P/S Ratio
Price to sales ratio
89.61
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
169.07
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.04
vs 25 benchmark
ROA
Return on assets percentage
0.04
vs 25 benchmark
ROCE
Return on capital employed
-0.03
vs 25 benchmark
How TRANSCHEM.BO Stacks Against Its Sector Peers
| Metric | TRANSCHEM.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 74.54 | 29.45 | Worse (Expensive) |
| ROE | 3.70% | 779.00% | Weak |
| Net Margin | 120.92% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 169.07 | 4.65 | Strong Liquidity |
| ROA | 3.59% | -19344.00% (disorted) | Weak |
TRANSCHEM.BO outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Transchem Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation